BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 8515492)

  • 1. Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas.
    Shibata D; Schaeffer J; Li ZH; Capella G; Perucho M
    J Natl Cancer Inst; 1993 Jul; 85(13):1058-63. PubMed ID: 8515492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas.
    Minamoto T; Sawaguchi K; Mai M; Yamashita N; Sugimura T; Esumi H
    Cancer Res; 1994 Jun; 54(11):2841-4. PubMed ID: 8187064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas.
    Wistuba II; Miquel JF; Gazdar AF; Albores-Saavedra J
    Hum Pathol; 1999 Jan; 30(1):21-5. PubMed ID: 9923922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent p53 gene mutations in serrated adenomas of the colorectum.
    Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E
    J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K-ras and p53 mutations in DNA extracted from colonic epithelial cells exfoliated in faeces of patients with colorectal cancer.
    Notarnicola M; Cavallini A; Cardone R; Pezzolla F; Demma I; Di Leo A
    Dig Liver Dis; 2000 Mar; 32(2):131-6. PubMed ID: 10975788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K-RAS-2 gene mutations as predictors of metachronous colorectal adenomas.
    Nusko G; Sachse R; Mansmann U; Wittekind C; Hahn EG
    Scand J Gastroenterol; 1997 Oct; 32(10):1035-41. PubMed ID: 9361177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors.
    Kusaka T; Fukui H; Sano Y; Ueda Y; Chiba T; Fujimori T
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1151-7. PubMed ID: 11106095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study on the mutation of P53 and K-ras gene in colorectal adenomas and colorectal carcinomas].
    Xu W; Cheng Y; Shen XF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):821-6. PubMed ID: 23387205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence does not occur between gastric adenoma and adenocarcinoma.
    Maesawa C; Tamura G; Suzuki Y; Ogasawara S; Sakata K; Kashiwaba M; Satodate R
    J Pathol; 1995 Jul; 176(3):249-58. PubMed ID: 7674088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the ras genes in malignant and premalignant colorectal tumors.
    Glarakis IS; Savva S; Spandidos DA
    Oncol Rep; 1998; 5(6):1451-4. PubMed ID: 9769386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation.
    Kim H; Yang XL; Rosada C; Hamilton SR; August JT
    Arch Biochem Biophys; 1994 May; 310(2):504-7. PubMed ID: 7513984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of K-ras mutations in DNAs isolated from feces of patients with colorectal tumors by mutant-allele-specific amplification (MASA).
    Hasegawa Y; Takeda S; Ichii S; Koizumi K; Maruyama M; Fujii A; Ohta H; Nakajima T; Okuda M; Baba S
    Oncogene; 1995 Apr; 10(7):1441-5. PubMed ID: 7731696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel method for simultaneous analysis of p53 and K-ras mutations and p53 protein expression in single histologic sections.
    Yamashita K; Yoshida T; Shinoda H; Okayasu I
    Arch Pathol Lab Med; 2001 Mar; 125(3):347-52. PubMed ID: 11231481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K-ras-2 G-C and G-T transversions correlate with DNA aneuploidy in colorectal adenomas.
    Giaretti W; Pujic N; Rapallo A; Nigro S; Di Vinci A; Geido E; Risio M
    Gastroenterology; 1995 Apr; 108(4):1040-7. PubMed ID: 7698570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K-ras and p53 mutations in colonic lavage fluid of patients with colorectal neoplasias.
    Heinzlmann M; Neynaber S; Heldwein W; Folwaczny C
    Digestion; 2001; 63(4):229-33. PubMed ID: 11435722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of c-K-ras mutations in human gastrointestinal tumors.
    Arber N; Shapira I; Ratan J; Stern B; Hibshoosh H; Moshkowitz M; Gammon M; Fabian I; Halpern Z
    Gastroenterology; 2000 Jun; 118(6):1045-50. PubMed ID: 10833479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary.
    Enomoto T; Weghorst CM; Inoue M; Tanizawa O; Rice JM
    Am J Pathol; 1991 Oct; 139(4):777-85. PubMed ID: 1656759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine.
    Rashid A; Hamilton SR
    Gastroenterology; 1997 Jul; 113(1):127-35. PubMed ID: 9207270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A detailed analysis of the role of K-ras gene mutation in the progression of colorectal adenoma.
    Ohnishi T; Tomita N; Monden T; Ohue M; Yana I; Takami K; Yamamoto H; Yagyu T; Kikkawa N; Shimano T; Monden M
    Br J Cancer; 1997; 75(3):341-7. PubMed ID: 9020477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
    Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
    Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.